On March 6, 2025, the Senate Committee on Health, Education, Labor, and Pensions (HELP) held a confirmation hearing to consider the nomination of Dr. Martin Makary to be the Commissioner of the Food and Drug Administration (FDA). The hearing touched on several topics, including the FDA’s advisory committee on vaccines, the regulation of Mifepristone, prescription drugs/medical devices, and the impact of layoffs within the agency.
Menu